✦ LIBER ✦

A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Koh, P. Keng; Califano, R.; Dean, E.; Kosmin, J.; Ataman, O.; Jackson, A.; Blackhall, F.H.; Faivre-Finn, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial assessing the combination

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Combination of cisplatin, ifosfamide and

✍ Barón, FJ; Ceuva, JF; Vázquez, F; Candamio, S; Calvo, M; Menéndez, MD; Irigoyen, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Vorinostat, a Histone Deacetylase Inhibi

✍ Decker, R.H.; Gettinger, S.N.; Glazer, P.M.; Wilson, L.D. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

A phase I trial of the combination taxot

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 173 KB

159 Phase II trial of gemcitabine in com

✍ Mohedano, N.; Sanchez-Rovira, P.; Medina, B.; Flores-Gonzalez, E.; Moreno, M.A.; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Gefitinib in Combination With Gemcitabin

✍ Giaccone, G. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 430 KB